Abstract
Papers dealing with the 177Lu production technology are analyzed with the aim of evaluating the readiness of the existing processes to setting up regular large-scale production, which is the necessary condition for the progress of the market of 177Lu-based radiopharmaceuticals. This is now on the initial step of its development. The 177Lu production processes are based on irradiation of isotopically enriched 176Lu or 176Yb with reactor neutrons, followed by radiochemical processing of the irradiated targets. Specific production features are analyzed with emphasis on process aspects of the reactor and radiochemical stages. The evaluation shows that the presently reached level of the 177Lu production technology allows only the current demand of nuclear medicine for this radionuclide, corresponding to the initial step of its clinical use, to be met. Further growth of the market of 177Lu radiopharmaceuticals requires the upgrading of existing or construction of new facilities, which is possible only with significant improvement of both reactor and radiochemical processes.
Similar content being viewed by others
References
Pillai, M.R.A. and Knapp, F.F., Curr. Radiopharm., 2015, vol. 8, pp. 78–85.
Banerjee, S., Pillai, M.R.A., and Knapp, F.F., Chem. Rev., 2015, vol. 115, no. 8, pp. 2934–2974.
Anderson, J., Farmer, F.T., Inst, P., et al., Br. J. Radiol., 1960, pp. 374–378.
Pillai, M.R.A. and Knapp, F.F., J. Nucl. Med., 2011, vol. 52, no. 2, pp. 15–16.
The Supply of Medical Radioisotopes-An Economic Study of the Molybdenum-99 Supply Chain, Paris: OECD, 2010.
Firestone, R., Table of Isotopes, New York: Wiley, 1996, 8th ed.
Tarasov, V.A., Romanov, E.G., and Kuznetsov, R.A., Izv. Samarsk. Nauchn. Tsentra Ross. Akad. Nauk, 2013, vol. 15,no. 4 (5), pp. 1084–1090.
Zhernosekov, K.P., Perego, R.S., Dvorakova, Z., et al., Appl. Radiat. Isot., 2008, vol. 66, pp. 1218–1220.
Dvorakova, Z., Production and chemical processing of 177Lu for nuclear medicine at the Munich research reactor FRM-II, Dissertation, Inst. of Radiochemistry, Technical Univ. of Munich, 2007.
Pawlak, D., Parus, J.L., Sasinowska, I., and Miko-lajczak, R., J. Radioanal. Nucl. Chem., 2004, vol. 261, no. 2, pp. 469–472.
Toporov, Y.G., Tarasov, V.A., Andreyev, O.I., et al., in Research Coordination Meet. “Development of Therapeutic Radiopharmaceuticals Based on 177Lu for Radionuclide Therapy,” Vienna: IAEA, 2006, p. 152.
Dash, A., Pillai, M.R.A., and Knapp, F.F., Jr., Nucl. Med. Mol. Imag., 2015, vol. 49, no. 2, pp. 85–107.
Tarasov, V.A., Andreev, O.I., Romanov, E.G., et al., Curr. Radiopharm., 2015, vol. 8, pp. 95–106.
Vysokopotochnyi issledovatel’skii reactor SM (SM High-Flux Research Reactor), Research Inst. of Atomic Reactors, 2008–2017. URL: http://niiar.ru/node/102/.
Manual for Reactor Produced Radioisotopes: IAEA-TECDOC-1340, 2003.
Chakraborty, S., Vimalnath, K.V., Lohar, Sh.P., et al., J. Radioanal. Nucl. Chem., 2014, vol. 302, no. 1, pp. 233–243.
Dvorakova, Z., Henkelmann, R., Lin, X., et al., Appl. Radiat. Isot., 2008, vol. 66, pp. 147–151.
Knapp, F.F., Mirzadeh, S., Beets, A.L., et al., Proc. 5th Int. Conf. on Isotopes (5ICI), Chemaly, C., Allen, B.J., and Bonet, H., Eds., Brussels, April 25–29, 2005.
Duodu, G.O., Akaho, E.H.K., Serfor-Aman, Y., and Nyarko, B.J.B., Appl. Radiat. Isot., 2011, vol. 69, pp. 588–593.
Das, T., Chakraborty, S., Banerjee, S., and Venkatesh, M.,Appl. Radiat. Isot., 2007, vol. 65, pp. 301–308.
The Rules Governing Medicinal Products in the European Union, vol. 4: EU Guidelines for Good Manufacturing Practice for Medicinal Products for Human and Veterinary Use, URL: https://ec.europa.eu/health/documents/eudralex/vol-4_en.
Marsh, J.K., J. Chem. Soc., 1942, pp. 398–401.
Marsh, J.K., J. Chem. Soc., 1943, pp. 8–10.
Lebedev, N.A., Novgorodov, A.F., Misiak, R., et al., Appl. Radiat. Isot., 2000, vol. 53, pp. 421–425.
Boldyrev, P.P., Kurochkin, A.V., Nurtdinov, R.F., et al., Vestn. Mosk Univ., Ser. 2: Khimiya, 2016, vol. 57, no. 3, pp. 184–190.
Boldyrev, P.P., Kurochkin, A.V., Proshin, M.A., et al., Radiochemistry, 2016, vol. 58, no. 5, pp. 498–505.
Boldyrev, P.P., Zagryadskii, V.A., Erak, D.Yu., et al., At. Energy, 2017, vol. 121, no. 3, pp. 208–213.
Lawless, F.R. and Wahlgren, M.A., J. Radioanal. Chem., 1970, vol. 5, pp. 11–20.
Chakravarty, R., Das, T., Dash, A., and Venkatesh, M., Nucl. Med. Biol., 2010, vol. 27, pp. 811–820.
Extraction Chromatography, Brown, T. and Ghersi-ni, G., Eds., Budapest: Akad. Kiado, 1975.
Ryabchikov, D.I. and Ryabukhin, V.A.,Analiticheskaya khimiya redkozemel ’nykh elementov i ittriya (Analytical Chemistry of Rare Earth Elements and Yttrium), Moscow: Nauka, 1966.
Triskem International, 2018, URL: http://www.triskem-international.com/ru/.
Mirzadeh, S., Du, M., Beets, A.L., and Knapp, F.F., Patent US 6716353, April 6, 2004.
Horwitz, E.P., McAlister, D.R., Bond, A.H., et al., Appl. Radiat. Isot., 2005, vol. 63, pp. 23–36.
Le Van So and Morcos, N., J. Radioanal. Nucl. Chem., 2008, vol. 277, no. 3, pp. 651–661.
Le Van So, Morcos, N., Zaw, M., et al., J. Radioanal. Nucl. Chem., 2008, vol. 277, no. 3, pp. 663–673.
Le Van So, Morcos, N., Zaw, M., et al., J. Radioanal. Nucl. Chem., 2008, vol. 277, no. 3, pp. 675–683.
Marx, S., Harfensteiler, M., Zhernosekov, K., and Nikula, T., US Patent Appl. 20140294700, Oct. 2, 2014.
Boldyrev, P.P., Vereshchagin, Yu.L, Zagryadskii, V.A., et al., Patent RU 2542733, Priority of Aug. 30, 2013.
Pillai, M.R.A., Chakraborty, S., Das, T., et al., Appl. Radiat. Isot., 2003, vol. 59, pp. 109–118.
Chakraborty, S., Chakravarty, R., Shetty, P., et al., J. Label. Compd. Radiopharm., 2016, vol. 59, no. 9, pp. 364–371.
Dash, A., Chakravarty, R., Knapp, F.F., and Pillai, M.R.A., Curr. Radiopharm., 2015, vol. 8, pp. 107–118.
Dash, A., Chakraborty, S., Pillai, M.R.A., and Knapp, F.F., Cancer Biother. Radiopharm., 2015, vol. 30, no. 2, pp. 47–71.
Paras, J.L., Pawlak, D., Mikoliajczak, R., and Duat-ti, A., Curr. Radiopharm., 2015, vol. 8, pp. 86–94.
Banerjee, S., Das, T., Chakraborty, S., and Venka-tesh, M., Radiochim. Acta, 2012, vol. 100, pp. 115–126.
Breeman, W.A.P., de Jong, M., Visser, T.J., et al., Eur. J. Nucl. Med. Mol. Imag., 2003, vol. 30, no. 6, pp. 917–920.
Asti, M., Tegoni, M., Farioli, D., et al., Nucl. Med. Biol, 2012, vol. 39, pp. 509–517.
Watanabe, S., Hashimoto, K., and Ishioka, N.S., J. Radioanal. Nucl. Chem., 2015, vol. 303, pp. 1519–1521.
Rosh, F., J. Nucl. Med., 2010, vol. 51, no. 3, pp. 495–496.
Chakravarty, R., Chakraborty, S., Dash, A., and Pillai, M.R.A., Nucl. Med. Biol., 2013, vol. 40, pp. 197–205.
Šimeček, J., Hermann, P., Wester, H.-J., and Notai, J., ChemMedChem, 2013, vol. 8, pp. 95–103.
Oehlke, E., Le, V.S., Lengkeek, N., et al., Appl. Radiat. Isot., 2013, vol. 82, pp. 232–238.
Eppard, E., Wuttke, M., Nicodemus, P.L., and Rosh, F., J. Nucl. Med., 2014, vol. 55, pp. 1023–1028.
Funding
The study was supported by the Ministry of Education and Science of the Russian Federation, contract no. 02.G25.31.0155.
Author information
Authors and Affiliations
Corresponding author
Additional information
Conflict of Interest
The authors declare that they have no conflict of interest.
Russian Text © The Author(s), 2019, published in Radiokhimiya, 2019, Vol. 61, No. 4, pp. 273–285.
Rights and permissions
About this article
Cite this article
Kuznetsov, R.A., Bobrovskaya, K.S., Svetukhin, V.V. et al. Production of Lutetium-177: Process Aspects. Radiochemistry 61, 381–395 (2019). https://doi.org/10.1134/S1066362219040015
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1066362219040015